Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SWI/SNF complex in cancer.

Literature DB >> 28138149

SWI/SNF complex in cancer.

Abstract

Four studies in this issue report new mechanisms underlying the function of the chromatin remodeling SWI/SNF complex in controlling gene expression and suppressing tumor development, providing valuable insights into the treatment of cancers harboring mutations in genes encoding SWI/SNF complex subunits.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2017 PMID： 28138149 PMCID： PMC5617137 DOI： 10.1038/ng.3779

Source DB: PubMed Journal: Nat Genet ISSN： 1061-4036 Impact factor: 38.330

14 in total

1. Five SWI genes are required for expression of the HO gene in yeast.

Authors: M Stern; R Jensen; I Herskowitz
Journal: J Mol Biol Date: 1984-10-05 Impact factor: 5.469

Review 2. Maintaining cell identity: PRC2-mediated regulation of transcription and cancer.

Authors: Itys Comet; Eva M Riising; Benjamin Leblanc; Kristian Helin
Journal: Nat Rev Cancer Date: 2016-09-23 Impact factor: 60.716

3. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex.

Authors: H Kwon; A N Imbalzano; P A Khavari; R E Kingston; M R Green
Journal: Nature Date: 1994-08-11 Impact factor: 49.962

4. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors: Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal: Nat Genet Date: 2013-05-05 Impact factor: 38.330

5. Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae.

Authors: L Neigeborn; M Carlson
Journal: Genetics Date: 1984-12 Impact factor: 4.562

6. Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.

Authors: Benjamin Z Stanton; Courtney Hodges; Joseph P Calarco; Simon M G Braun; Wai Lim Ku; Cigall Kadoch; Keji Zhao; Gerald R Crabtree
Journal: Nat Genet Date: 2016-12-12 Impact factor: 38.330

7. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.

Authors: Benjamin G Bitler; Katherine M Aird; Azat Garipov; Hua Li; Michael Amatangelo; Andrew V Kossenkov; David C Schultz; Qin Liu; Ie-Ming Shih; Jose R Conejo-Garcia; David W Speicher; Rugang Zhang
Journal: Nat Med Date: 2015-02-16 Impact factor: 53.440

8. ARID1B is a specific vulnerability in ARID1A-mutant cancers.

Authors: Katherine C Helming; Xiaofeng Wang; Boris G Wilson; Francisca Vazquez; Jeffrey R Haswell; Haley E Manchester; Youngha Kim; Gregory V Kryukov; Mahmoud Ghandi; Andrew J Aguirre; Zainab Jagani; Zhong Wang; Levi A Garraway; William C Hahn; Charles W M Roberts
Journal: Nat Med Date: 2014-02-23 Impact factor: 53.440

9. Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states.

Authors: Cigall Kadoch; Robert T Williams; Joseph P Calarco; Erik L Miller; Christopher M Weber; Simon M G Braun; John L Pulice; Emma J Chory; Gerald R Crabtree
Journal: Nat Genet Date: 2016-12-12 Impact factor: 38.330

10. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.

Authors: Xiaofeng Wang; Ryan S Lee; Burak H Alver; Jeffrey R Haswell; Su Wang; Jakub Mieczkowski; Yotam Drier; Shawn M Gillespie; Tenley C Archer; Jennifer N Wu; Evgeni P Tzvetkov; Emma C Troisi; Scott L Pomeroy; Jaclyn A Biegel; Michael Y Tolstorukov; Bradley E Bernstein; Peter J Park; Charles W M Roberts
Journal: Nat Genet Date: 2016-12-12 Impact factor: 38.330

33 in total

Review 1. Chromatin-Remodeled State in Lymphoma.

Authors: Yuxuan Liu; Yulissa Gonzalez; Jennifer E Amengual
Journal: Curr Hematol Malig Rep Date: 2019-10 Impact factor: 3.952

2. Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining.

Authors: Junior Tayou
Journal: Cell Oncol (Dordr) Date: 2018-04-20 Impact factor: 6.730

3. cBAF complex components and MYC cooperate early in CD8⁺ T cell fate.

Authors: Ao Guo; Hongling Huang; Zhexin Zhu; Mark J Chen; Hao Shi; Sujing Yuan; Piyush Sharma; Jon P Connelly; Swantje Liedmann; Yogesh Dhungana; Zhenrui Li; Dalia Haydar; Mao Yang; Helen Beere; Jason T Yustein; Christopher DeRenzo; Shondra M Pruett-Miller; Jeremy Chase Crawford; Giedre Krenciute; Charles W M Roberts; Hongbo Chi; Douglas R Green
Journal: Nature Date: 2022-06-22 Impact factor: 69.504

4. The impact of ARID1A mutation on molecular characteristics in colorectal cancer.

Authors: Ryuma Tokunaga; Joanne Xiu; Richard M Goldberg; Philip A Philip; Andreas Seeber; Francesca Battaglin; Hiroyuki Arai; Jae Ho Lo; Madiha Naseem; Alberto Puccini; Martin D Berger; Shivani Soni; Wu Zhang; Sting Chen; Jimmy J Hwang; Anthony F Shields; John L Marshall; Hideo Baba; W Michael Korn; Heinz-Josef Lenz
Journal: Eur J Cancer Date: 2020-10-17 Impact factor: 9.162

Review 5. EZH2-Targeted Therapies in Cancer: Hype or a Reality.

Authors: Marie-Lisa Eich; James E Ferguson; Sooryanarayana Varambally; Mohammad Athar
Journal: Cancer Res Date: 2020-09-25 Impact factor: 12.701

6. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).

Authors: Jiang Du; Si Wang; Rui Wang; Si-Yao Wang; Qiang Han; Hong-Tao Xu; Peng Yang; Yang Liu
Journal: Pathol Oncol Res Date: 2019-11-22 Impact factor: 3.201